UGT1A1 and Decreased total neutrophil count: For instance, with irinotecan treatment, up to 50% of Western patients with the UGT1A1*28 allele suffered from severe neutropenia [3,4], and these findings led to the recommendation to consider a reduced initial dose for patients known to be homozygous for the UGT1A1*28 allele.